Cargando…
Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function
Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after suppl...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024688/ https://www.ncbi.nlm.nih.gov/pubmed/29865234 http://dx.doi.org/10.3390/nu10060714 |
_version_ | 1783336109963476992 |
---|---|
author | Fan, Dawei Alamri, Yassar Liu, Karen MacAskill, Michael Harris, Paul Brimble, Margaret Dalrymple-Alford, John Prickett, Tim Menzies, Oliver Laurenson, Andrew Anderson, Tim Guan, Jian |
author_facet | Fan, Dawei Alamri, Yassar Liu, Karen MacAskill, Michael Harris, Paul Brimble, Margaret Dalrymple-Alford, John Prickett, Tim Menzies, Oliver Laurenson, Andrew Anderson, Tim Guan, Jian |
author_sort | Fan, Dawei |
collection | PubMed |
description | Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after supplementing blackcurrant anthocyanins (BCA), which may be associated with IGF-1 function. We evaluated the changes of cGP and IGF-1 before and after the supplementation. Methods: Plasma and cerebrospinal fluid (CSF) were collected from 11 male patients before and after 28 day supplementation of BCA. The concentrations of IGF-1, IGF binding protein (IGFBP)-3, and cGP were measured using ELISA and HPLC-MS assays. The presence of cGP in the BCA was evaluated. Results: cGP presented in the BCA. BCA supplementation increased the concentration of cGP (p < 0.01), but not IGF-1 and IGFBP-3 in the CSF. CSF concentration of cGP was correlated with plasma concentration of cGP (R = 0.68, p = 0.01) and cGP/IGF-1 molar ratio (R = 0.66, p = 0.01). The CSF/plasma ratio was high in cGP and low in IGF-1 and IGFBP-3. Conclusion: cGP is a natural nutrient to the BCA. The increased CSF cGP in Parkinson disease patients may result from the central uptake of plasma cGP. Given neurotrophic function, oral availability, and effective central uptake of cGP, the BCA has the potential to be developed to treat neurological conditions with IGF-1 deficiency. |
format | Online Article Text |
id | pubmed-6024688 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60246882018-07-08 Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function Fan, Dawei Alamri, Yassar Liu, Karen MacAskill, Michael Harris, Paul Brimble, Margaret Dalrymple-Alford, John Prickett, Tim Menzies, Oliver Laurenson, Andrew Anderson, Tim Guan, Jian Nutrients Article Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after supplementing blackcurrant anthocyanins (BCA), which may be associated with IGF-1 function. We evaluated the changes of cGP and IGF-1 before and after the supplementation. Methods: Plasma and cerebrospinal fluid (CSF) were collected from 11 male patients before and after 28 day supplementation of BCA. The concentrations of IGF-1, IGF binding protein (IGFBP)-3, and cGP were measured using ELISA and HPLC-MS assays. The presence of cGP in the BCA was evaluated. Results: cGP presented in the BCA. BCA supplementation increased the concentration of cGP (p < 0.01), but not IGF-1 and IGFBP-3 in the CSF. CSF concentration of cGP was correlated with plasma concentration of cGP (R = 0.68, p = 0.01) and cGP/IGF-1 molar ratio (R = 0.66, p = 0.01). The CSF/plasma ratio was high in cGP and low in IGF-1 and IGFBP-3. Conclusion: cGP is a natural nutrient to the BCA. The increased CSF cGP in Parkinson disease patients may result from the central uptake of plasma cGP. Given neurotrophic function, oral availability, and effective central uptake of cGP, the BCA has the potential to be developed to treat neurological conditions with IGF-1 deficiency. MDPI 2018-06-02 /pmc/articles/PMC6024688/ /pubmed/29865234 http://dx.doi.org/10.3390/nu10060714 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fan, Dawei Alamri, Yassar Liu, Karen MacAskill, Michael Harris, Paul Brimble, Margaret Dalrymple-Alford, John Prickett, Tim Menzies, Oliver Laurenson, Andrew Anderson, Tim Guan, Jian Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function |
title | Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function |
title_full | Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function |
title_fullStr | Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function |
title_full_unstemmed | Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function |
title_short | Supplementation of Blackcurrant Anthocyanins Increased Cyclic Glycine-Proline in the Cerebrospinal Fluid of Parkinson Patients: Potential Treatment to Improve Insulin-Like Growth Factor-1 Function |
title_sort | supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of parkinson patients: potential treatment to improve insulin-like growth factor-1 function |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024688/ https://www.ncbi.nlm.nih.gov/pubmed/29865234 http://dx.doi.org/10.3390/nu10060714 |
work_keys_str_mv | AT fandawei supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT alamriyassar supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT liukaren supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT macaskillmichael supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT harrispaul supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT brimblemargaret supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT dalrymplealfordjohn supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT pricketttim supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT menziesoliver supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT laurensonandrew supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT andersontim supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function AT guanjian supplementationofblackcurrantanthocyaninsincreasedcyclicglycineprolineinthecerebrospinalfluidofparkinsonpatientspotentialtreatmenttoimproveinsulinlikegrowthfactor1function |